Related Experiment Video
Updated: Jun 17, 2026
09:46
Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
Published on: December 27, 2017
Pathogenesis and management of essential thrombocythemia
Philip A Beer1, Anthony R Green
1Department of Haematology, University of Cambridge, Cambridge, United Kingdom.
Hematology. American Society of Hematology. Education Program
|December 17, 2009
Summary
Recent advances have significantly improved understanding of myeloproliferative neoplasms. This review highlights new insights into essential thrombocythemia, focusing on its overlap with polycythemia vera and primary myelofibrosis.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Myeloproliferative neoplasms (MPNs) are a group of clonal hematopoietic stem cell disorders.
- Recent years have brought significant advancements in understanding MPN pathogenesis.
- Key developments include new diagnostic tools and a clearer view of MPN interrelationships.
Purpose of the Study:
- To review recent developments in the pathogenesis and management of essential thrombocythemia (ET).
- To emphasize the phenotypic overlap between ET, polycythemia vera (PV), and primary myelofibrosis (PMF).
Main Methods:
- Literature review of recent studies on MPNs.
- Focus on molecular mechanisms, diagnostics, and disease relationships.
- Analysis of phenotypic similarities and differences between ET, PV, and PMF.
Main Results:
- Explosion in understanding MPN molecular mechanisms.
- Development of novel diagnostic tests for MPNs.
- Improved comprehension of the relationships between different MPN entities.
Conclusions:
- Essential thrombocythemia shares phenotypic characteristics with polycythemia vera and primary myelofibrosis.
- Continued research is crucial for refining MPN diagnosis and management.
- Understanding molecular pathogenesis is key to targeted therapies for MPNs.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
01:28Role of Hematopoietic Growth Factors
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...